Aclaris Therapeutics, INC. (ACRS) SEC Filings — 2025

Filings

• Aclaris' Net Loss Widens 27% Amid Soaring R&D Costs — 10-Q · Nov 6, 2025
• Aclaris Therapeutics Files 8-K — 8-K · Oct 14, 2025
• Aclaris' Q2 Loss Widens to $24.7M Amid R&D Pipeline Focus — 10-Q · Aug 7, 2025
• Aclaris Therapeutics Files 8-K — 8-K · Jul 29, 2025
• Aclaris Therapeutics Files 8-K — 8-K · Jun 30, 2025
• Aclaris Therapeutics Files 8-K with Corporate Governance Updates — 8-K · Jun 5, 2025
• Aclaris Therapeutics Q1 2025 10-Q Filing — 10-Q · May 8, 2025
• Aclaris Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 24, 2025
• Aclaris Therapeutics Files 2024 Annual Report — 10-K · Feb 27, 2025
• Aclaris Therapeutics Files 8-K — 8-K · Jan 13, 2025